ChloroquineV1, Ncbi, Merge, bibRecord, 000C47

A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients

Identifieur interne : 000C47 ( Ncbi/Merge ); précédent : 000C46; suivant : 000C48

A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients

Auteurs : Feng Tian ; Jing-Yang Li ; Zhen-Hua Wen ; Xiao-Wen Luo ; Li Deng ; Liang Zhang ; Jing-Yun He

Source :

Medicine [ 0025-7974 ] ; 2019.

RBID : PMC:6890288

Abstract

Supplemental Digital Content is available in the text

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890288

DOI: 10.1097/MD.0000000000017750
PubMed: 31770193
PubMed Central: 6890288

Links toward previous steps (curation, corpus...)

to stream Pmc, to step Corpus: 000695
to stream Pmc, to step Curation: 000695
to stream Pmc, to step Checkpoint: 000A55

Links to Exploration step

PMC:6890288

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients</title>
<author><name sortKey="Tian, Feng" sort="Tian, Feng" uniqKey="Tian F" first="Feng" last="Tian">Feng Tian</name>
</author>
<author><name sortKey="Li, Jing Yang" sort="Li, Jing Yang" uniqKey="Li J" first="Jing-Yang" last="Li">Jing-Yang Li</name>
</author>
<author><name sortKey="Wen, Zhen Hua" sort="Wen, Zhen Hua" uniqKey="Wen Z" first="Zhen-Hua" last="Wen">Zhen-Hua Wen</name>
</author>
<author><name sortKey="Luo, Xiao Wen" sort="Luo, Xiao Wen" uniqKey="Luo X" first="Xiao-Wen" last="Luo">Xiao-Wen Luo</name>
</author>
<author><name sortKey="Deng, Li" sort="Deng, Li" uniqKey="Deng L" first="Li" last="Deng">Li Deng</name>
</author>
<author><name sortKey="Zhang, Liang" sort="Zhang, Liang" uniqKey="Zhang L" first="Liang" last="Zhang">Liang Zhang</name>
</author>
<author><name sortKey="He, Jing Yun" sort="He, Jing Yun" uniqKey="He J" first="Jing-Yun" last="He">Jing-Yun He</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">31770193</idno>
<idno type="pmc">6890288</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890288</idno>
<idno type="RBID">PMC:6890288</idno>
<idno type="doi">10.1097/MD.0000000000017750</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000695</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000695</idno>
<idno type="wicri:Area/Pmc/Curation">000695</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000695</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000A55</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000A55</idno>
<idno type="wicri:Area/Ncbi/Merge">000C47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients</title>
<author><name sortKey="Tian, Feng" sort="Tian, Feng" uniqKey="Tian F" first="Feng" last="Tian">Feng Tian</name>
</author>
<author><name sortKey="Li, Jing Yang" sort="Li, Jing Yang" uniqKey="Li J" first="Jing-Yang" last="Li">Jing-Yang Li</name>
</author>
<author><name sortKey="Wen, Zhen Hua" sort="Wen, Zhen Hua" uniqKey="Wen Z" first="Zhen-Hua" last="Wen">Zhen-Hua Wen</name>
</author>
<author><name sortKey="Luo, Xiao Wen" sort="Luo, Xiao Wen" uniqKey="Luo X" first="Xiao-Wen" last="Luo">Xiao-Wen Luo</name>
</author>
<author><name sortKey="Deng, Li" sort="Deng, Li" uniqKey="Deng L" first="Li" last="Deng">Li Deng</name>
</author>
<author><name sortKey="Zhang, Liang" sort="Zhang, Liang" uniqKey="Zhang L" first="Liang" last="Zhang">Liang Zhang</name>
</author>
<author><name sortKey="He, Jing Yun" sort="He, Jing Yun" uniqKey="He J" first="Jing-Yun" last="He">Jing-Yun He</name>
</author>
</analytic>
<series><title level="j">Medicine</title>
<idno type="ISSN">0025-7974</idno>
<idno type="eISSN">1536-5964</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Supplemental Digital Content is available in the text</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Chinese Rheumatology, A" uniqKey="Chinese Rheumatology A">A Chinese Rheumatology</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mcinnes, Ib" uniqKey="Mcinnes I">IB McInnes</name>
</author>
<author><name sortKey="Schett, G" uniqKey="Schett G">G Schett</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Smolen, Js" uniqKey="Smolen J">JS Smolen</name>
</author>
<author><name sortKey="Aletaha, D" uniqKey="Aletaha D">D Aletaha</name>
</author>
<author><name sortKey="Mcinnes, Ib" uniqKey="Mcinnes I">IB McInnes</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Burmester, Gr" uniqKey="Burmester G">GR Burmester</name>
</author>
<author><name sortKey="Pope, Je" uniqKey="Pope J">JE Pope</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Malmstrom, V" uniqKey="Malmstrom V">V Malmstrom</name>
</author>
<author><name sortKey="Catrina, Ai" uniqKey="Catrina A">AI Catrina</name>
</author>
<author><name sortKey="Klareskog, L" uniqKey="Klareskog L">L Klareskog</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lefevre, S" uniqKey="Lefevre S">S Lefevre</name>
</author>
<author><name sortKey="Knedla, A" uniqKey="Knedla A">A Knedla</name>
</author>
<author><name sortKey="Tennie, C" uniqKey="Tennie C">C Tennie</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Isaacs, Jd" uniqKey="Isaacs J">JD Isaacs</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Brennan, A" uniqKey="Brennan A">A Brennan</name>
</author>
<author><name sortKey="Bansback, N" uniqKey="Bansback N">N Bansback</name>
</author>
<author><name sortKey="Nixon, R" uniqKey="Nixon R">R Nixon</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Brennan, A" uniqKey="Brennan A">A Brennan</name>
</author>
<author><name sortKey="Bansback, N" uniqKey="Bansback N">N Bansback</name>
</author>
<author><name sortKey="Reynolds, A" uniqKey="Reynolds A">A Reynolds</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Soini, Ej" uniqKey="Soini E">EJ Soini</name>
</author>
<author><name sortKey="Hallinen, Ta" uniqKey="Hallinen T">TA Hallinen</name>
</author>
<author><name sortKey="Puolakka, K" uniqKey="Puolakka K">K Puolakka</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bansback, N" uniqKey="Bansback N">N Bansback</name>
</author>
<author><name sortKey="Phibbs, Cs" uniqKey="Phibbs C">CS Phibbs</name>
</author>
<author><name sortKey="Sun, H" uniqKey="Sun H">H Sun</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jalal, H" uniqKey="Jalal H">H Jalal</name>
</author>
<author><name sortKey="O Ell, Jr" uniqKey="O Ell J">JR O’Dell</name>
</author>
<author><name sortKey="Bridges, Sl" uniqKey="Bridges S">SL Bridges</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chen, Xx" uniqKey="Chen X">XX Chen</name>
</author>
<author><name sortKey="Dai, Q" uniqKey="Dai Q">Q Dai</name>
</author>
<author><name sortKey="Huang, Ab" uniqKey="Huang A">AB Huang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chen, Xx" uniqKey="Chen X">XX Chen</name>
</author>
<author><name sortKey="Li, Zg" uniqKey="Li Z">ZG Li</name>
</author>
<author><name sortKey="Wu, Hx" uniqKey="Wu H">HX Wu</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Carreno, A" uniqKey="Carreno A">A Carreno</name>
</author>
<author><name sortKey="Fernandez, I" uniqKey="Fernandez I">I Fernandez</name>
</author>
<author><name sortKey="Badia, X" uniqKey="Badia X">X Badia</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wouters, Oj" uniqKey="Wouters O">OJ Wouters</name>
</author>
<author><name sortKey="Naci, H" uniqKey="Naci H">H Naci</name>
</author>
<author><name sortKey="Samani, Nj" uniqKey="Samani N">NJ Samani</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Davies, A" uniqKey="Davies A">A Davies</name>
</author>
<author><name sortKey="Cifaldi, Ma" uniqKey="Cifaldi M">MA Cifaldi</name>
</author>
<author><name sortKey="Segurado, Og" uniqKey="Segurado O">OG Segurado</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
<journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
<journal-id journal-id-type="publisher-id">MEDI</journal-id>
<journal-title-group><journal-title>Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0025-7974</issn>
<issn pub-type="epub">1536-5964</issn>
<publisher><publisher-name>Wolters Kluwer Health</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">31770193</article-id>
<article-id pub-id-type="pmc">6890288</article-id>
<article-id pub-id-type="publisher-id">MD-D-19-02687</article-id>
<article-id pub-id-type="doi">10.1097/MD.0000000000017750</article-id>
<article-id pub-id-type="art-access-id">17750</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>6900</subject>
</subj-group>
<subj-group><subject>Research Article</subject>
<subject>Observational Study</subject>
</subj-group>
</article-categories>
<title-group><article-title>A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Tian</surname>
<given-names>Feng</given-names>
</name>
<degrees>MM</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname>
<given-names>Jing-Yang</given-names>
</name>
<degrees>MB</degrees>
<xref rid="cor1" ref-type="corresp"><sup>∗</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Wen</surname>
<given-names>Zhen-Hua</given-names>
</name>
<degrees>MM</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Luo</surname>
<given-names>Xiao-Wen</given-names>
</name>
<degrees>MB</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Deng</surname>
<given-names>Li</given-names>
</name>
<degrees>MM</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname>
<given-names>Liang</given-names>
</name>
<degrees>MB</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>He</surname>
<given-names>Jing-Yun</given-names>
</name>
<degrees>MB</degrees>
</contrib>
</contrib-group>
<contrib-group><contrib contrib-type="editor"><name><surname>Tsuji.</surname>
<given-names>Fumio</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Rheumatology and Immunology, ZhuZhou Central Hospital, The Affiliated ZhuZhou Hospital XiangYa Medical College CSU, Zhuzhou, China.</aff>
<author-notes id="cor1"><corresp><label>∗</label>
Correspondence: Jing-Yang Li, Department of Rheumatology and Immunology, ZhuZhou Central Hospital, The Affiliated ZhuZhou Hospital XiangYa Medical College CSU, 116 South Changjiang Road, Tianyuan District, Zhuzhou 412007, China (e-mail: <email>yongchuo3173423355@163.com</email>
).</corresp>
</author-notes>
<pub-date pub-type="collection"><month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub"><day>27</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>98</volume>
<issue>48</issue>
<elocation-id>e17750</elocation-id>
<history><date date-type="received"><day>13</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="rev-recd"><day>27</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted"><day>02</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions><copyright-statement>Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>
</license-p>
</license>
</permissions>
<self-uri xlink:type="simple" xlink:href="medi-98-e17750.pdf"></self-uri>
<abstract abstract-type="toc"><p>Supplemental Digital Content is available in the text</p>
</abstract>
<abstract><title>Abstract</title>
<p>The aim of this study was to evaluate the cost-effectiveness of Anbainuo (ABN) plus methotrexate (MTX) (ABN + MTX) versus conventional disease-modifying anti-rheumatic drugs (cDMARDs) in rheumatoid arthritis (RA) patients.</p>
<p>Forty-eight moderate to severe RA patients underwent ABN + MTX or cDMARDs treatment were consecutively enrolled and assigned to ABN + MTX group (n = 26) and control group (n = 22). Patients were followed up and their disease activity and quality of life (QoL) were evaluated at 3rd month, 6th month and 12th month after initiation of treatment. Treatment costs of 2 groups were calculated, then pharmacoeconomic analysis was performed.</p>
<p>ABN + MTX increased drug cost and total cost while decreased indirect cost compared with cDMARDs after 12-month treatment. ABN + MTX group gained additional 0.22 quality-adjusted life years (QALY) and yielded an incremental cost-effectiveness ratio (ICER) of ¥104,293.6 per QALY after treatment. Sensitivity analysis reveals that rising ABN price by 20% produced an ICER of ¥130,403.6 per QALY, which was still lower than 3 times of the mean gross domestic product (GDP) per capita during the same period in China (¥165,960). Besides, ABN + MTX was more cost-effective in severe RA patients compared to moderate RA patients.</p>
<p>ABN + MTX is cost-effective in treating moderate to severe RA patients compared with cDMARDs, although the total cost of ABN + MTX is relatively higher.</p>
</abstract>
<kwd-group><title>Keywords</title>
<kwd>anbainuo</kwd>
<kwd>conventional disease modifying antirheumatic drugs</kwd>
<kwd>cost-effectiveness</kwd>
<kwd>price</kwd>
<kwd>rheumatoid arthritis</kwd>
</kwd-group>
<custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name>
<meta-value>TRUE</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations><list></list>
<tree><noCountry><name sortKey="Deng, Li" sort="Deng, Li" uniqKey="Deng L" first="Li" last="Deng">Li Deng</name>
<name sortKey="He, Jing Yun" sort="He, Jing Yun" uniqKey="He J" first="Jing-Yun" last="He">Jing-Yun He</name>
<name sortKey="Li, Jing Yang" sort="Li, Jing Yang" uniqKey="Li J" first="Jing-Yang" last="Li">Jing-Yang Li</name>
<name sortKey="Luo, Xiao Wen" sort="Luo, Xiao Wen" uniqKey="Luo X" first="Xiao-Wen" last="Luo">Xiao-Wen Luo</name>
<name sortKey="Tian, Feng" sort="Tian, Feng" uniqKey="Tian F" first="Feng" last="Tian">Feng Tian</name>
<name sortKey="Wen, Zhen Hua" sort="Wen, Zhen Hua" uniqKey="Wen Z" first="Zhen-Hua" last="Wen">Zhen-Hua Wen</name>
<name sortKey="Zhang, Liang" sort="Zhang, Liang" uniqKey="Zhang L" first="Liang" last="Zhang">Liang Zhang</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C47 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000C47 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     PMC:6890288
   |texte=   A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:31770193" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients

A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki